View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
GMALL 08/2013 - B-ALL/NHL 2002 Regimen, 18 - 55, Part C
Protocol-ID: 347 V1.1 (Mini), GMALL 08/2013-B-ALL/NHL 2002 Regimen, 18 - 55, Part CIndication(s)
- Acute Lymphoblastic Leukaemia (B-ALL); ICD-10 C91.0-
- NHL, B-Cell Type, Anaplastic Large Cell Lymphoma, ALK-Positive; ICD-10 C84.6
- NHL, B-Cell Type, Burkitt's Lymphoma; ICD-10 C83.7
- NHL, B-Cell Type, Lymphoblastic Lymphoma; ICD-10 C83.5
Links
- Studie GMALL08_2013, Treatment Optimization in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment - a Phase IV-trial With a Phase III-part to Evaluate Safety and Efficacy of Nelarabine in T-ALL Patients [clinicaltrials.gov]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 27.06.2016